Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Search
Buscar
Buscar
Congreso SOLACI
SOLACI-CACI 2024
Certificados SOLACI-CACI 24
Presentaciones destacadas día 1
Presentaciones destacadas día 2
Presentaciones destacadas día 3
Notas y cobertura
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Novedades Científicas
Cardiopatía estructural
Enfermedad coronaria
Enfermedad vascular periférica
Farmacología
Boletines educativos para fellows
Webinars educativos
Otras publicaciones
Congresos
Congreso SOLACI-CACI 2024
Congresos internacionales
Congresos SOLACI
Próximos eventos
Áreas SOLACI
Jornadas
Jornadas El Salvador 2024
Jornadas Arequipa 2024
Jornadas Realizadas
Acerca de Jornadas
Autoridades
Novedades
ProEducar
Boletines Educativos
Cursos de Fellows
Rincón del Fellow
Videos y Webinars ProEducar
Novedades
SOLACI Research
Registro LATAM-SOLACI Peripheral
Registro LATAM Bif-SOLACI
Sea parte de nuestros registros
Guías Clínicas SOLACI / SIAC
Autoridades
Videos y Webinars
Novedades
SOLACI Peripheral
Registro LATAM-SOLACI Peripheral
Videos y Webinars
Autoridades
Novedades
Grupo MIL
Actividades e iniciativas
Videos y Webinars
Historia, misión y visión
Autoridades
CHIP LATAM
Autoridades
Novedades
SOL SOLACI
Autoridades
Cardiopatías Congénitas
Autoridades
Novedades Cardiopatías Congénitas
Técnicos y Enfermeros
Autoridades
Webinars y videos
Novedades
Acerca de SOLACI
Quiénes somos
Comisión directiva
Directorio de profesionales
Asóciese a SOLACI
Sociedades vinculadas
Noticias Institucionales
Contacto
Home
Novedades Científicas
Cardiopatía estructural
Enfermedad coronaria
Enfermedad vascular periférica
Farmacología
Boletines educativos para fellows
Webinars educativos
Otras publicaciones
Congresos
Congreso SOLACI-CACI 2024
Congresos internacionales
Congresos SOLACI
Próximos eventos
Áreas SOLACI
Jornadas
Jornadas El Salvador 2024
Jornadas Arequipa 2024
Jornadas Realizadas
Acerca de Jornadas
Autoridades
Novedades
ProEducar
Boletines Educativos
Cursos de Fellows
Rincón del Fellow
Videos y Webinars ProEducar
Novedades
SOLACI Research
Registro LATAM-SOLACI Peripheral
Registro LATAM Bif-SOLACI
Sea parte de nuestros registros
Guías Clínicas SOLACI / SIAC
Autoridades
Videos y Webinars
Novedades
SOLACI Peripheral
Registro LATAM-SOLACI Peripheral
Videos y Webinars
Autoridades
Novedades
Grupo MIL
Actividades e iniciativas
Videos y Webinars
Historia, misión y visión
Autoridades
CHIP LATAM
Autoridades
Novedades
SOL SOLACI
Autoridades
Cardiopatías Congénitas
Autoridades
Novedades Cardiopatías Congénitas
Técnicos y Enfermeros
Autoridades
Webinars y videos
Novedades
Acerca de SOLACI
Quiénes somos
Comisión directiva
Directorio de profesionales
Asóciese a SOLACI
Sociedades vinculadas
Noticias Institucionales
Contacto
Artículos del autor
Dr. Carlos Fava
Member of the Editorial Board of solaci.org
Mitral valve
Evolution at 1 Year for the PARTNER 3 Mitral Valve-in-Valve Study
At present, the structural failure of mitral bioprostheses due to their deterioration poses a significant challenge. While...
Dr. Carlos Fava
-
20 September, 2024
Mitral valve
Edge-to-Edge Tricuspid Valve Repair 3-Year Follow Up
Tricuspid regurgitation (TR) is associated to fatigue and peripheral edema, and medical treatment with diuretics has a...
Dr. Carlos Fava
-
18 September, 2024
Antithrombotic Anticoagulants
Should We Withdraw Anticoagulation Before TAVR?
Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral...
Dr. Carlos Fava
-
17 September, 2024
Acute coronary syndromes
Recently Diagnosed Atrial Fibrillation in Patients with Acute Coronary Syndrome: Results of the FORCE-ACS Registry
Atrial fibrillation (AF) is a common condition in patients with acute coronary syndrome (ACS). About 10% of...
Dr. Carlos Fava
-
17 September, 2024
Structural heart disease
MATTERHORN: Edge-to-Edge Repair vs. Surgery for Secondary Mitral Valve Regurgitation
Frequently associated with hospitalization for cardiac failure and mortality, secondary mitral valve regurgitation (MR) is the most...
Dr. Carlos Fava
-
13 September, 2024
Structural heart disease
RESHAPE-HF2 Trial: Edge-to-Edge Repair in Secondary Mitral Valve Regurgitation vs. Complete Medical Treatment
Severe secondary Mitral Valve Regurgitation (MR) has been associated with increased hospitalization and mortality. Even though optimal...
Dr. Carlos Fava
-
9 September, 2024
Coronary disease
¿What Should We Do About Significant Coronary Lesions in TAVR?
Aortic stenosis and coronary artery disease (CAD) share risk factors, which means significant lesions will coexist in...
Dr. Carlos Fava
-
6 September, 2024
Structural heart disease
Do Leadless Pacemakers After TAVR Offer Benefits?
The need for pacemaker after transcatheter aortic valve replacement (TAVR) remains slightly higher than with surgery, especially...
Dr. Carlos Fava
-
20 August, 2024